The therapy, called photobiomodulation or “red light” therapy, can reduce the risk of vision loss and slow progression of the ...

Nutritional supplements that contain curcumin -- a natural anti-inflammatory compound -- may protect the eyes from the ...

Dr. Shiri Shulman from Assuta discusses the importance of continuity in treatment during wartime and innovative therapies ...

In the Comparison of Age-Related Macular Degeneration Treatment Trials (CATT) study, currently enrolling 1200 patients, attention is focused on comparisons of bevacizumab and ranibizumab monotherapy.

Preliminary data from a late stage clinical trial of a retinal implant showed promising results, Science Corporation said ...

A new statistical models shed light on why some patients can extend the dosing interval with Eylea (aflibercept) from 8 weeks ...

An investigational antibody demonstrated an ability to preserve vision in people with geographic atrophy from dry age-related ...

The following is a summary of “Submacular hemorrhage rates following anti-vascular endothelial growth factor injections for ...

Roche has released positive topline one-year findings from a Phase IV trial of Vabysmo (faricimab) to treat diabetic macular ...

Pharmaceuticals announced that the first patient has been dosed in the Phase 3 LUGANO clinical trial of DURAVYU, formerly ...